KB Home reports results for the quarter ended May 31 - Earnings Summary
KB Home reports results for the quarter ended May 31 - Earnings Summary
KB Home KBH.N reported quarterly adjusted earnings of 43 cents per share for the quarter ended May 31, lower than the same quarter last year, when the company reported EPS of $1.50. The mean expectation of fifteen analysts for the quarter was for earnings of 45 cents per share. Wall Street expected results to range from 39 cents to 52 cents per share.
Revenue fell 27.3% to $1.11 billion from a year ago; analysts expected $1.10 billion.
KB Home's reported EPS for the quarter was 43 cents.
The company reported quarterly net income of $27.35 million.
KB Home shares had risen by 1.5% this quarter and lost 6.9% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 33.2% in the last three months.
In the last 30 days, three analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy," 10 "hold" and 4 "sell" or "strong sell." The average consensus recommendation for the homebuilding peer group is "buy."
Wall Street's median 12-month price target for KB Home is $56.00, about 5.8% above its last closing price of $52.73
This summary was machine generated from LSEG data June 23 at 09:02 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
May. 31 2026 | 0.45 | 0.43 | Missed |
Feb. 28 2026 | 0.55 | 0.56 | Beat |
Nov. 30 2025 | 1.80 | 1.92 | Beat |
Aug. 31 2025 | 1.50 | 1.61 | Beat |
Recent news on KB Home
See all newsUS homebuilders advance after Congress passes affordable housing bill
KB Home reports results for the quarter ended May 31 - Earnings Summary
KB Home Q2 revenue falls on fewer homes delivered
Preview: US homebuilders brace for another challenging year as war, tariffs hurt margins
U.S. STOCKS ON THE MOVE-ADMA Biologics, Nanobiotix, DraftKings